Management of Lupus Nephritis: New Treatments and Updated Guidelines

Management of lupus nephritis has evolved considerably over the past years. Here, we provide a comprehensive review of clinical trials that form the basis for the Kidney Disease: Improving Global Outcomes and EULAR/ERA-EDTA updated guidelines and present day trials that will change the landscape of...

Descripción completa

Detalles Bibliográficos
Autores principales: Avasare, Rupali, Drexler, Yelena, Caster, Dawn J., Mitrofanova, Alla, Jefferson, J. Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Nephrology 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617804/
https://www.ncbi.nlm.nih.gov/pubmed/37528520
http://dx.doi.org/10.34067/KID.0000000000000230
_version_ 1785129653787164672
author Avasare, Rupali
Drexler, Yelena
Caster, Dawn J.
Mitrofanova, Alla
Jefferson, J. Ashley
author_facet Avasare, Rupali
Drexler, Yelena
Caster, Dawn J.
Mitrofanova, Alla
Jefferson, J. Ashley
author_sort Avasare, Rupali
collection PubMed
description Management of lupus nephritis has evolved considerably over the past years. Here, we provide a comprehensive review of clinical trials that form the basis for the Kidney Disease: Improving Global Outcomes and EULAR/ERA-EDTA updated guidelines and present day trials that will change the landscape of lupus nephritis therapy in years to come. In addition, we highlight the issues related to cost of therapy, resistant disease, and downstream adverse effects of specific therapies.
format Online
Article
Text
id pubmed-10617804
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society of Nephrology
record_format MEDLINE/PubMed
spelling pubmed-106178042023-11-01 Management of Lupus Nephritis: New Treatments and Updated Guidelines Avasare, Rupali Drexler, Yelena Caster, Dawn J. Mitrofanova, Alla Jefferson, J. Ashley Kidney360 Review Article Management of lupus nephritis has evolved considerably over the past years. Here, we provide a comprehensive review of clinical trials that form the basis for the Kidney Disease: Improving Global Outcomes and EULAR/ERA-EDTA updated guidelines and present day trials that will change the landscape of lupus nephritis therapy in years to come. In addition, we highlight the issues related to cost of therapy, resistant disease, and downstream adverse effects of specific therapies. American Society of Nephrology 2023-10-26 /pmc/articles/PMC10617804/ /pubmed/37528520 http://dx.doi.org/10.34067/KID.0000000000000230 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Review Article
Avasare, Rupali
Drexler, Yelena
Caster, Dawn J.
Mitrofanova, Alla
Jefferson, J. Ashley
Management of Lupus Nephritis: New Treatments and Updated Guidelines
title Management of Lupus Nephritis: New Treatments and Updated Guidelines
title_full Management of Lupus Nephritis: New Treatments and Updated Guidelines
title_fullStr Management of Lupus Nephritis: New Treatments and Updated Guidelines
title_full_unstemmed Management of Lupus Nephritis: New Treatments and Updated Guidelines
title_short Management of Lupus Nephritis: New Treatments and Updated Guidelines
title_sort management of lupus nephritis: new treatments and updated guidelines
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617804/
https://www.ncbi.nlm.nih.gov/pubmed/37528520
http://dx.doi.org/10.34067/KID.0000000000000230
work_keys_str_mv AT avasarerupali managementoflupusnephritisnewtreatmentsandupdatedguidelines
AT drexleryelena managementoflupusnephritisnewtreatmentsandupdatedguidelines
AT casterdawnj managementoflupusnephritisnewtreatmentsandupdatedguidelines
AT mitrofanovaalla managementoflupusnephritisnewtreatmentsandupdatedguidelines
AT jeffersonjashley managementoflupusnephritisnewtreatmentsandupdatedguidelines

Ejemplares similares